00:00 Brian
A lot of viewers of this program, they have made bank. They have made bank in Mac 7. Uh not only this year, the year before and the year before that, maybe even a couple years before. They’re they’re sitting on a lot of gains is what I’m trying to say. What should they be doing right now with these gains?
00:14 George
Good morning, Brian. Can you imagine being a short seller in this market and trying to bet against the the Mag 7 or the AI trade or anything. I mean, you get carried out. Short selling’s been like the worst uh possible thesis on the market you could have the last 15 years other than maybe going long oil and gas stocks. So I I I would not bet against any of any of these complexes, any of these movements. You want to talk about earnings growth, this market’s got it. A lot of the other developed countries really don’t. So betting against the US has been a fool’s game and I’m certainly not going to be doing it in 2026. I’m going not I’m be going to not try to time the market. I’m going to try to stay in there, stay positions as is and just trim and reallocate as as wisdom would would dictate.
01:05 Brian
George, I just had a a guest on uh I’m doing double duty here. I was in the 9:00 a.m. hour and they were making the case for healthcare. If you had to stack up these two sectors side by side, you got uh AI plays, you got the Mac 7, healthcare. What excites you more and why?
01:22 George
Yeah, I don’t really like any of those the best. I think healthcare’s seen a significant rally in the closing parts of 2025. If you look at Johnson and Johnson, which basically just lagged in the 140s to 170s, uh kind of era era for a long time and now it’s well over 200. You’ve already seen somewhat of a healthcare rally. If I was going to move chips around the table, I would stay focused on small caps and international. And believe it or not, even though I just ridiculed them, I’d I’d look at oil and gas stocks. They’re incredibly cheap, they’re incredibly out of favor and the risk reward of that is is pretty compelling from a one to two-year perspective in my view.
